Gilead's former general counsel — key to drug maker's battle against Covid, HIV and hepatitis C — lands at Peninsula law firm
Brett Pletcher spent nearly 18 years at Gilead during the company's biggest expansion stage to a multibillion-dollar drug maker. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 14, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Single-Visit Sample Collection Recommended for Hep C Testing
FRIDAY, July 14, 2023 -- Use of strategies that require multiple visits to collect blood for hepatitis C virus (HCV) testing should be discontinued and replaced by single-visit sample collection, according to research published in the July 14 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2023 Category: Pharmaceuticals Source Type: news
Diagnosis of Viral Hepatitis Is Still a Major Challenge Diagnosis of Viral Hepatitis Is Still a Major Challenge
World Hepatitis Day is an opportunity to remind people of the impact of viral hepatitis and to offer information that can help prevent, diagnose, and treat these diseases, said one expert.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - July 14, 2023 Category: Primary Care Tags: Infectious Diseases News Source Type: news
Hepatitis C Vaccine Is Essential for Expediting Elimination
(MedPage Today) -- The 2022 World Health Organization (WHO) report estimated 58 million people live with chronic hepatitis C, while approximately 40% of people are unaware of their infection. The hepatitis C virus (HCV) genome, discovered in 1989... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 13, 2023 Category: Gastroenterology Source Type: news
Updated Operational Guidance for Implementing CDC's Recommendations on Testing for Hepatitis C Virus Infection
This report describes new CDC guidance for completing hepatitis C virus testing. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 13, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
South Africa: Breakthrough Hepatitis C Cures Slowly Becoming More Widely Available
[spotlight] Almost a decade after they were first proven to be safe and highly effective, game-changing medicines to cure hepatitis C are finally becoming more widely available in South Africa. But not all the regulatory and other challenges behind the delay have yet been overcome and, as a result, access remains relatively limited for now. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 13, 2023 Category: African Health Tags: Health and Medicine South Africa Southern Africa Source Type: news
S2 Episode 5: HIV, Primary Care Treatment, and Vaccines S2 Episode 5: HIV, Primary Care Treatment, and Vaccines
Drs Michael S. Saag and David H. Spach discuss HIV and the nuances of primary care treatment, with a special focus on vaccines, including COVID, hepatitis, varicella zoster virus, and mpox.Medscape (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 13, 2023 Category: Infectious Diseases Tags: HIV/AIDS InDiscussion Source Type: news
A Decade After First DAA, Only 1 in 3 Are HCV Free A Decade After First DAA, Only 1 in 3 Are HCV Free
Patients with hepatitis C virus (HCV) infection face barriers at every step, from diagnosis to accessing breakthrough direct-acting antiviral (DAA) medications, experts say.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 12, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Bulevirtide for Hep D: Phase 3 Data Now Published in NEJM Bulevirtide for Hep D: Phase 3 Data Now Published in NEJM
Bulevirtide, an investigational, first-in-class hepatitis delta virus entry-inhibitor, significantly reduced viral load and normalized liver enzymes in patients.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 7, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Global Treatment Rate and Barriers to DAA Therapy Global Treatment Rate and Barriers to DAA Therapy
A better understanding of the common barriers to DAA treatment for chronic hepatitis C will help increase treatment rates and improve access.Liver International (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 7, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
New Treatment Gives Hope to Chronic Hepatitis D Patients
A drug called bulevirtide marks the first treatment option available to hepatitis D patients since the discovery of the virus in 1977. Real-world results are promising. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 6, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Hepatitis C Treatments: A Comprehensive Guide
THURSDAY, July 6, 2023 -- Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly reported cases of chronic hepatitis C?
To help you... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 6, 2023 Category: General Medicine Source Type: news
Learn the Differences Between Hepatitis A, B, C, D & E
THURSDAY, July 6, 2023 -- Curious about what the differences are between hepatitis A, B, C, D and E? If so, you ’ve come to the right place. Here, experts break down hepatitis infection by type to reveal what it is, the most common symptoms, how... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 6, 2023 Category: General Medicine Source Type: news
Bulevirtide Linked to Decline in Hepatitis D Virus RNA Levels
FRIDAY, June 30, 2023 -- For patients with hepatitis D virus (HDV), bulevirtide is associated with a reduction in HDV RNA levels and alanine aminotransferase (ALT) levels, according to a study published online June 22 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2023 Category: Pharmaceuticals Source Type: news
'Jarringly' Low Hep C Cure Rates a Decade After New Treatments, CDC Says
(MedPage Today) -- Only one in three U.S. adults infected with hepatitis C virus (HCV) have been cured since direct-acting antivirals became available 10 years ago, CDC data showed.
Among 1 million adults with evidence of initial infection using... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 30, 2023 Category: American Health Source Type: news
